Solvonis Therapeutics Plc (SVNS)
LSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 29k | 330k | 219k | 587k |
| Operating Income | -405k | -671k | -450k | -946k | -2.28M |
| Pre Tax Income | -494k | -703k | -538k | -954k | -3.12M |
| Net Income | -494k | -703k | -538k | -954k | -3.12M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.7 | -1 | -0.8 | -1.4 | -3 |
| EBIT | -405k | -671k | -450k | -946k | -2.28M |
| EBITDA | -397k | -602k | -336k | -844k | -2.1M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
